Selected research
Industry Growth & Trends
Global Weight Reduction Medicine Industry Growth and Trends Forecast to 2032
Market perspective
The global Weight Reduction Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Weight Reduction Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Weight Reduction Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Weight Reduction Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Weight Reduction Medicine include Teva, Sandoz(Novartis), Roche, GSK group, Zein Pharmaceutical, Taj Pharmaceuticals Ltd, STADA-VN J.V.Co., Ltd, National Company For Pharmaceutical Industry and Lunan Pharmaceutical Group Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Weight Reduction Medicine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Weight Reduction Medicine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Weight Reduction Medicine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Weight Reduction Medicine.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Weight Reduction Medicine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Weight Reduction Medicine Market by Company
Teva
Sandoz(Novartis)
Roche
GSK group
Zein Pharmaceutical
Taj Pharmaceuticals Ltd
STADA-VN J.V.Co., Ltd
National Company For Pharmaceutical Industry
Lunan Pharmaceutical Group Corporation
Kabir Life Sciences & Research
Hisun
Hexal AG
Dm Pharma
China Zhongshan Pharm
Weight Reduction Medicine Segment by Type
Liauid
Tablets
Weight Reduction Medicine Segment by Application
Weight-reducing Aid
Other
Weight Reduction Medicine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Weight Reduction Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Weight Reduction Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Weight Reduction Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Weight Reduction Medicine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Weight Reduction Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Liauid
- Tablets
Applications
- Weight-reducing Aid
- Other
Companies covered
- Teva
- Sandoz(Novartis)
- Roche
- GSK group
- Zein Pharmaceutical
- Taj Pharmaceuticals Ltd
- STADA-VN J.V.Co., Ltd
- National Company For Pharmaceutical Industry
- Lunan Pharmaceutical Group Corporation
- Kabir Life Sciences & Research
- Hisun
- Hexal AG
- Dm Pharma
- China Zhongshan Pharm
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Weight Reduction Medicine Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Weight Reduction Medicine Sales Estimates and Forecasts (2021-2032)
- 1.3 Weight Reduction Medicine Market by Type
- 1.3.1 Liauid
- 1.3.2 Tablets
- 1.4 Global Weight Reduction Medicine Market Size by Type
- 1.4.1 Global Weight Reduction Medicine Market Size Overview by Type (2021-2032)
- 1.4.2 Global Weight Reduction Medicine Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Weight Reduction Medicine Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Weight Reduction Medicine Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Weight Reduction Medicine Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Weight Reduction Medicine Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Weight Reduction Medicine Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Weight Reduction Medicine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Weight Reduction Medicine Industry Trends
- 2.2 Weight Reduction Medicine Industry Drivers
- 2.3 Weight Reduction Medicine Industry Opportunities and Challenges
- 2.4 Weight Reduction Medicine Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Weight Reduction Medicine Revenue (2021-2026)
- 3.2 Global Top Players by Weight Reduction Medicine Sales (2021-2026)
- 3.3 Global Top Players by Weight Reduction Medicine Price (2021-2026)
- 3.4 Global Weight Reduction Medicine Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Weight Reduction Medicine Major Company Production Sites & Headquarters
- 3.6 Global Weight Reduction Medicine Company, Product Type & Application
- 3.7 Global Weight Reduction Medicine Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Weight Reduction Medicine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Weight Reduction Medicine Players Market Share by Revenue in 2025
- 3.8.3 2025 Weight Reduction Medicine Tier 1, Tier 2, and Tier 3
4 Weight Reduction Medicine Regional Status and Outlook
- 4.1 Global Weight Reduction Medicine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Weight Reduction Medicine Historic Market Size by Region
- 4.2.1 Global Weight Reduction Medicine Sales in Volume by Region (2021-2026)
- 4.2.2 Global Weight Reduction Medicine Sales in Value by Region (2021-2026)
- 4.2.3 Global Weight Reduction Medicine Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Weight Reduction Medicine Forecasted Market Size by Region
- 4.3.1 Global Weight Reduction Medicine Sales in Volume by Region (2027-2032)
- 4.3.2 Global Weight Reduction Medicine Sales in Value by Region (2027-2032)
- 4.3.3 Global Weight Reduction Medicine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Weight Reduction Medicine by Application
- 5.1 Weight Reduction Medicine Market by Application
- 5.1.1 Weight-reducing Aid
- 5.1.2 Other
- 5.2 Global Weight Reduction Medicine Market Size by Application
- 5.2.1 Global Weight Reduction Medicine Market Size Overview by Application (2021-2032)
- 5.2.2 Global Weight Reduction Medicine Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Weight Reduction Medicine Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Weight Reduction Medicine Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Weight Reduction Medicine Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Weight Reduction Medicine Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Weight Reduction Medicine Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Weight Reduction Medicine Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Teva
- 6.1.1 Teva Company Information
- 6.1.2 Teva Business Overview
- 6.1.3 Teva Weight Reduction Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Teva Weight Reduction Medicine Product Portfolio
- 6.1.5 Teva Recent Developments
- 6.2 Sandoz(Novartis)
- 6.2.1 Sandoz(Novartis) Company Information
- 6.2.2 Sandoz(Novartis) Business Overview
- 6.2.3 Sandoz(Novartis) Weight Reduction Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Sandoz(Novartis) Weight Reduction Medicine Product Portfolio
- 6.2.5 Sandoz(Novartis) Recent Developments
- 6.3 Roche
- 6.3.1 Roche Company Information
- 6.3.2 Roche Business Overview
- 6.3.3 Roche Weight Reduction Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Roche Weight Reduction Medicine Product Portfolio
- 6.3.5 Roche Recent Developments
- 6.4 GSK group
- 6.4.1 GSK group Company Information
- 6.4.2 GSK group Business Overview
- 6.4.3 GSK group Weight Reduction Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 GSK group Weight Reduction Medicine Product Portfolio
- 6.4.5 GSK group Recent Developments
- 6.5 Zein Pharmaceutical
- 6.5.1 Zein Pharmaceutical Company Information
- 6.5.2 Zein Pharmaceutical Business Overview
- 6.5.3 Zein Pharmaceutical Weight Reduction Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Zein Pharmaceutical Weight Reduction Medicine Product Portfolio
- 6.5.5 Zein Pharmaceutical Recent Developments
- 6.6 Taj Pharmaceuticals Ltd
- 6.6.1 Taj Pharmaceuticals Ltd Company Information
- 6.6.2 Taj Pharmaceuticals Ltd Business Overview
- 6.6.3 Taj Pharmaceuticals Ltd Weight Reduction Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Taj Pharmaceuticals Ltd Weight Reduction Medicine Product Portfolio
- 6.6.5 Taj Pharmaceuticals Ltd Recent Developments
- 6.7 STADA-VN J.V.Co., Ltd
- 6.7.1 STADA-VN J.V.Co., Ltd Company Information
- 6.7.2 STADA-VN J.V.Co., Ltd Business Overview
- 6.7.3 STADA-VN J.V.Co., Ltd Weight Reduction Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 STADA-VN J.V.Co., Ltd Weight Reduction Medicine Product Portfolio
- 6.7.5 STADA-VN J.V.Co., Ltd Recent Developments
- 6.8 National Company For Pharmaceutical Industry
- 6.8.1 National Company For Pharmaceutical Industry Company Information
- 6.8.2 National Company For Pharmaceutical Industry Business Overview
- 6.8.3 National Company For Pharmaceutical Industry Weight Reduction Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 National Company For Pharmaceutical Industry Weight Reduction Medicine Product Portfolio
- 6.8.5 National Company For Pharmaceutical Industry Recent Developments
- 6.9 Lunan Pharmaceutical Group Corporation
- 6.9.1 Lunan Pharmaceutical Group Corporation Company Information
- 6.9.2 Lunan Pharmaceutical Group Corporation Business Overview
- 6.9.3 Lunan Pharmaceutical Group Corporation Weight Reduction Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Lunan Pharmaceutical Group Corporation Weight Reduction Medicine Product Portfolio
- 6.9.5 Lunan Pharmaceutical Group Corporation Recent Developments
- 6.10 Kabir Life Sciences & Research
- 6.10.1 Kabir Life Sciences & Research Company Information
- 6.10.2 Kabir Life Sciences & Research Business Overview
- 6.10.3 Kabir Life Sciences & Research Weight Reduction Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Kabir Life Sciences & Research Weight Reduction Medicine Product Portfolio
- 6.10.5 Kabir Life Sciences & Research Recent Developments
- 6.11 Hisun
- 6.11.1 Hisun Company Information
- 6.11.2 Hisun Business Overview
- 6.11.3 Hisun Weight Reduction Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Hisun Weight Reduction Medicine Product Portfolio
- 6.11.5 Hisun Recent Developments
- 6.12 Hexal AG
- 6.12.1 Hexal AG Company Information
- 6.12.2 Hexal AG Business Overview
- 6.12.3 Hexal AG Weight Reduction Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Hexal AG Weight Reduction Medicine Product Portfolio
- 6.12.5 Hexal AG Recent Developments
- 6.13 Dm Pharma
- 6.13.1 Dm Pharma Company Information
- 6.13.2 Dm Pharma Business Overview
- 6.13.3 Dm Pharma Weight Reduction Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Dm Pharma Weight Reduction Medicine Product Portfolio
- 6.13.5 Dm Pharma Recent Developments
- 6.14 China Zhongshan Pharm
- 6.14.1 China Zhongshan Pharm Company Information
- 6.14.2 China Zhongshan Pharm Business Overview
- 6.14.3 China Zhongshan Pharm Weight Reduction Medicine Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 China Zhongshan Pharm Weight Reduction Medicine Product Portfolio
- 6.14.5 China Zhongshan Pharm Recent Developments
7 North America by Country
- 7.1 North America Weight Reduction Medicine Sales by Country
- 7.1.1 North America Weight Reduction Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Weight Reduction Medicine Sales by Country (2021-2026)
- 7.1.3 North America Weight Reduction Medicine Sales Forecast by Country (2027-2032)
- 7.2 North America Weight Reduction Medicine Market Size by Country
- 7.2.1 North America Weight Reduction Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Weight Reduction Medicine Market Size by Country (2021-2026)
- 7.2.3 North America Weight Reduction Medicine Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Weight Reduction Medicine Sales by Country
- 8.1.1 Europe Weight Reduction Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Weight Reduction Medicine Sales by Country (2021-2026)
- 8.1.3 Europe Weight Reduction Medicine Sales Forecast by Country (2027-2032)
- 8.2 Europe Weight Reduction Medicine Market Size by Country
- 8.2.1 Europe Weight Reduction Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Weight Reduction Medicine Market Size by Country (2021-2026)
- 8.2.3 Europe Weight Reduction Medicine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Weight Reduction Medicine Sales by Country
- 9.1.1 Asia-Pacific Weight Reduction Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Weight Reduction Medicine Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Weight Reduction Medicine Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Weight Reduction Medicine Market Size by Country
- 9.2.1 Asia-Pacific Weight Reduction Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Weight Reduction Medicine Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Weight Reduction Medicine Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Weight Reduction Medicine Sales by Country
- 10.1.1 South America Weight Reduction Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Weight Reduction Medicine Sales by Country (2021-2026)
- 10.1.3 South America Weight Reduction Medicine Sales Forecast by Country (2027-2032)
- 10.2 South America Weight Reduction Medicine Market Size by Country
- 10.2.1 South America Weight Reduction Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Weight Reduction Medicine Market Size by Country (2021-2026)
- 10.2.3 South America Weight Reduction Medicine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Weight Reduction Medicine Sales by Country
- 11.1.1 Middle East and Africa Weight Reduction Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Weight Reduction Medicine Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Weight Reduction Medicine Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Weight Reduction Medicine Market Size by Country
- 11.2.1 Middle East and Africa Weight Reduction Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Weight Reduction Medicine Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Weight Reduction Medicine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Weight Reduction Medicine Value Chain Analysis
- 12.1.1 Weight Reduction Medicine Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Weight Reduction Medicine Production Mode & Process
- 12.2 Weight Reduction Medicine Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Weight Reduction Medicine Distributors
- 12.2.3 Weight Reduction Medicine Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst